In this randomized controlled trial, axatilimab effectively managed symptoms in patients with recurrent or refractory graft ...

In this cluster-randomized controlled trial, in communities with a high rate of opioid-related overdoses, the implementation ...

Just-in-time adherence support systems in gamified cognitive training should be applied when participants are failing to ...

This follow-up analysis of the phase 3 REPRIEVE trial demonstrated that region of residence, prediabetes, high BMI, and ...

In a cluster randomized clinical trial, electronic health record (EHR)-based intervention increased the frequency of ...

In this randomized controlled trial, twice daily crinecerfont use was associated with reduced daily glucocorticoid use in ...

In this randomized controlled trial of pediatric patients with congenital adrenal hyperplasia (CAH), it was found that ...

In this randomized controlled trial, among patients with moderately to severely active ulcerative colitis, tulisokibart, a ...

A higher body roundness index (BRI) trajectory is associated with an increased risk of cardiovascular disease (CVD). Evidence ...

In this randomized controlled trial, among patients with severe hypoxemia, long-term oxygen therapy used for 24 hours per day ...

In this secondary analysis of the MINT trial, 30-day risks for the composite outcome of death and recurrent myocardial ...

A phase 3 trial showed Kerendia reduced the risk of cardiovascular death by 16% compared to placebo. Hyperkalemia was greater ...